Grant Status: Active
Training Category: Healthy Tomorrows
Grant Title: Hablamos Juntos (Talking Together) Improving Childhood Language and Literacy
Altamed Health Services Corporation
Los Angeles, CA 90022
Phone: (323) 889-7343
The Hablamos Juntos (Talking Together) initiative at AltaMed's Children's Hospital Los Angeles (CHLA) clinic will serve over 2,000 annually through ASQ-3 screening and 370-420 during the project period through parent workshops for children needing additional interventions.
Goals and Objectives:
(1) Provide developmental screening for children from 6/9 months up to age 5 years old (2) Conduct pediatrician led 5 week parent workshops for children who score in the yellow zone with potential language delays on the ASQ-3; and (3) Conduct Speech Language Therapist (SLT) led 12 week parent workshops for children who score in the red zone, requiring additional assessment, on the ASQ-3.
In 2014, AltaMed was awarded a First 5 Los Angeles grant to implement clinic-wide electronic screenings for developmental delays using the Ages and Stages Questionnaire (ASQ-3) for all eligible patients aged 9, 18, and 24/30 months old. AltaMed will leverage this infrastructure and its partnership with Children's Hospital Los Angeles to implement Hablamos Juntos (Talking Together), a comprehensive initiative to improve childhood language development and literacy. This project aims to improve rates of early intervention for low income, Latino children with language delays, reducing the wide disparity in health outcomes between this population and other groups. Families enrolled in the parent workshops will receive training using the Hanen Centre's It Takes Two to Talk curriculum to improve childhood language development and coordination support through 211 Los Angeles and family resource centers to connect families with additional support services.
AltaMed will leverage this infrastructure and its partnership with Children's Hospital Los Angeles to implement Hablamos Juntos (Talking Together).
AltaMed will collect data on children aged 0-5 receiving ASQ-3 screenings during well-child visits, including the number in the red and yellow zones for developmental delays. Children and families in the red and yellow zones will be referred for parent workshops. Altamed will collect data on referrals, the number of parents who attend the workshops, and the number who complete the workshops. Finally, Advisory Board engagement will be assessed annually. In terms of outcomes, parents will be assessed for knowledge change using the MacArthur Bates CDI tool. Speech-Language Pathologists will assess parent-child interactions using in-person and video visits before and after participation in workshops.